Peter Laverman
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Radiopharmaceutical Chemistry and Applications 36
- Medical Imaging Techniques and Applications 21
- Monoclonal and Polyclonal Antibodies Research 8
- Oncology 24
- Peptidase Inhibition and Analysis 18
- Co-authors
- Otto C. Boerman (82 shared papers)Wim J.G. Oyen (67 shared papers)Frans H.M. Corstens (29 shared papers)Gert Storm (17 shared papers)E.T.M. Dams (16 shared papers)David M. Goldenberg (10 shared papers)William J. McBride (10 shared papers)Robert M. Sharkey (7 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (16 papers)Journal of Nuclear Medicine (11 papers)Bioconjugate Chemistry (6 papers)Nuclear Medicine and Biology (6 papers)Molecular Imaging and Biology (4 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Peter Laverman
126 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 136
- Radiology, Nuclear Medicine and Imaging 2.1k
- Biomaterials 1.0k
- Pharmaceutical Science 371
- Oncology 1.1k
- Cancer Research 333
Countries citing papers authored by Peter Laverman
This map shows the geographic impact of Peter Laverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Laverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Laverman more than expected).
Fields of papers citing papers by Peter Laverman
This network shows the impact of papers produced by Peter Laverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Laverman. The network helps show where Peter Laverman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Laverman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 479 | |
| 2 | 2009 | 327 | |
| 3 | 2001 | 241 | |
| 4 | 2010 | 187 | |
| 5 | 2002 | 173 | |
| 6 | 2009 | 162 | |
| 7 | 2002 | 158 | |
| 8 | 2010 | 133 | |
| 9 | 2012 | 100 | |
| 10 | 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. | 2000 | 99 |
| 11 | 2000 | 96 | |
| 12 | 2015 | 87 | |
| 13 | 2011 | 84 | |
| 14 | A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. | 1999 | 79 |
| 15 | 2008 | 78 | |
| 16 | 2013 | 76 | |
| 17 | 2010 | 75 | |
| 18 | 2015 | 71 | |
| 19 | 2006 | 71 | |
| 20 | 1999 | 68 |
About Peter Laverman
Peter Laverman is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Surgery, Biomaterials and Pulmonary and Respiratory Medicine, having authored 126 papers that have together received 5.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (36 papers), Medical Imaging Techniques and Applications (21 papers), Peptidase Inhibition and Analysis (18 papers), Nanoparticle-Based Drug Delivery (14 papers), Orthopedic Infections and Treatments (13 papers), Neuroendocrine Tumor Research Advances (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Medical Imaging and Pathology Studies (8 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.1k citations), Biomaterials (1.0k citations), Pharmaceutical Science (371 citations), Oncology (1.1k citations) and Cancer Research (333 citations). Peter Laverman has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Otto C. Boerman, Wim J.G. Oyen, Frans H.M. Corstens, Gert Storm, E.T.M. Dams, David M. Goldenberg, William J. McBride, Robert M. Sharkey, Gerben M. Franssen and J.W.M. van der Meer. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, Bioconjugate Chemistry, Nuclear Medicine and Biology and Molecular Imaging and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.